Hospital Microbiology Testing Market: Overview
Clinical microbiology plays an important
role in an individual’s health and helps to manage infectious disease
outbreak by identifying pathogens having potential to infect people.
Hospital microbiology testing is a part of clinical laboratory testing
involved in conducting multiple tests and blood collections in
hospitals. It enables adequate management of threats of infectious
diseases. Timeliness of diagnosis, appropriateness of treatment,
advances in infectious disease practices and training of future
practitioners are some of the factors driving the global hospital
microbiology testing market.
Maintaining high quality microbiological
laboratories in hospitals is currently the best approach for management
of emerging infectious diseases. Intense focus on controlling healthcare
expenditure has led to important changes in managing various infectious
diseases. Additionally, hospital based microbiology testing enables
effective communication between the physician and microbiology
laboratory is other important aspect of on-site microbiology testing.
Also, training future healthcare practitioners in hospitals is made easy
due to ready access to microbiology laboratory. Such trainings are
bound to get hampered in cases where microbiology testing laboratories
are at distant location from hospitals.
Hospital Microbiology Testing Market: Segmentation
The global hospital microbiology testing
market can be segmented based on disease type tests for AIDS, antrax,
babesiosis, Candida, Adenovirus, Chancroid, chagas disease,
Campylobacter, Brucella, Blastocystis hominis, Chlamydia,
Cytomegalovirus, Clostridium difficile, Coxsackieviruses,
Creutzfeldt-Jakob’s disease, Coronaviruses, Cyclospora cayetanensis, E.
Coli, Ebola Virus, EchoVirus, Enteroviruses, Encephalitis, Epstein-Barr
virus, Gonorrhea, Giardia lamblia, West Nile Virus, Tuberculosis,
Trichomonas vaginalis, Toxoplasmosis, Syphilis, Streptococci,
Staphylococcus aureus and various others.
The market is also segmented based on the
diagnostic technologies used in global hospital microbiology testing
market. The diagnostic technologies include molecular diagnostics,
monoclonal antibodies, immunoassays, differential light scattering,
liposome, flow cytometry, chromatography, gel microdroplets and others.
Geographically, the global hospital microbiology testing market is
segmented into four major regions namely, North America, Europe,
Asia-Pacific and Rest of the World.
Hospital Microbiology Testing Market: Trends and Drivers
Hospital microbiology testing overcomes
the drawback of the important aspects such as specimen handling and
transport. Delay in transportation of the specimen in distant
laboratories not only impacts the testing but also the integrity of the
specimen. This may lead to a false positive or false negative result of
analysis which can be life threatening. Few examples which show broad
variety of specimen samples are affected by delay in transport or
testing include overgrowth of Shigella species or death of meningococci
in cerebrospinal fluid if not cultured rapidly which in many cases may
lead to false negative results.
Thus these issues are better addressed by
inoculating specimens the hospitals itself and then transported to
centralized laboratories if required. This initial process dictates the
need of technologists and expertise in clinical microbiology and not
generalist since initial processing of microbiology samples is critical.
In addition, reductions in reimbursement
provided by governmental healthcare providers have led most of the
hospitals and medical centers to undertake enhancement of their
microbiological laboratory capabilities. It has also been suggested that
hospital based microbiology laboratories should be offered easily
obtainable annual grants depending on the hospital size and criticality
of care.
With growing attention focused on
increase in infectious diseases and improved quality of healthcare
outcomes, it appears that managing of infectious disease can be best
accomplished by maintaining microbiological testing laboratories on the
same site i.e. in hospitals to promote good patient care outcomes and
also to save money. Thus the goal of hospital microbiology testing
includes achievement of excellence in patient care, affordable diagnosis
and treatment and high quality outcome. Some of the key players
contributing to the microbiology testing market include Abbott
Diagnostics, Affymetrix, bioMerieux, Cepheid, Hologic, Ortho-Clinical
Diagnostics, Qiagen, Roche Diagnostics, Siemens and Thermo Fischer
Scientific.
The report offers a comprehensive
evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of
the market, including but not limited to: Regional markets, technology,
types, and applications.
No comments:
Post a Comment